SP

Shubhang Pandey

Active Director Director DIN 08298454
DIN 08298454 First appointment Dec 2018 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value •••• Premium profile

About Shubhang Pandey

Data last updated:

Shubhang Pandey is a Director at Prelude Pharmaceuticals Private Limited (since 2018). The company operates in Professional Services. Prelude Pharmaceuticals Private Limited reported revenue of ₹26,220 (FY 2024).

DIN 08298454
Primary Designation Director
Industry Professional Services
First Appointment 15 Dec 2018
Oldest Company Age 10 yrs
Largest company Prelude Pharmaceuticals Private Limited · ₹26,220 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Dec 20182015₹26,220 (FY 2024)Active

Board colleagues of Shubhang Pandey

Directorship timeline

Open interactive timeline →
Prelude Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shubhang Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhang Pandey

Shubhang Pandey currently holds 1 directorship: Prelude Pharmaceuticals Private Limited (Director, since 15 Dec 2018, revenue ₹26,220 (FY 2024)).

Shubhang Pandey was first appointed on 15 Dec 2018 as Director at Prelude Pharmaceuticals Private Limited.

The current boards of Shubhang Pandey's companies include Savita Pandey (Prelude Pharmaceuticals Private Limited), Seema Pandey (Prelude Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available